QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.013839v1 35/7/1126    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ng, V. Y. Articles by Kroetz, D. L. Search for Related Content PubMed PubMed Citation Articles by Ng, V. Y. Articles by Kroetz, D. L.

Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor

Department of Biopharmaceutical Sciences (V.Y.N., Y. H., E.T.L., D.L.K.) and the Liver Center (D.L.K.), University of California, San Francisco, San Francisco, California; and Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas (M.R., J.R.F.)

Cytochrome P450 (P450) eicosanoids regulate vascular tone, renal tubular transport, cellular proliferation, and inflammation. Both the CYP4A -hydroxylases, which catalyze 20-hydroxyeicosatetraenoic acid (20-HETE) formation, and soluble epoxide hydrolase (sEH), which catalyzes epoxyeicosatrienoic acid (EET) degradation to the dihydroxyeicosatrienoic acids (DHETs), are induced upon activation of peroxisome proliferator-activated receptor (PPAR) by fatty acids and fibrates. In contrast, the CYP2C epoxygenases, which are responsible for EET formation, are repressed after fibrate treatment. We show here that P450 eicosanoids can bind to and activate PPAR and result in the modulation of PPAR target gene expression. In transactivation assays, 14,15-DHET, 11,2-EET, and 20-HETE were potent activators of PPAR. Gel shift assays showed that EETs, DHETs, and 20-HETE induced PPAR-specific binding to its cognate response element. Expression of apolipoprotein A-I was decreased 70% by 20-HETE, whereas apolipoprotein A-II expression was increased up to 3-fold by 11,12-EET, 14,15-DHET, and 20-HETE. In addition, P450 eicosanoids induced CYP4A1, sEH, and CYP2C11 expression, suggesting that they can regulate their own levels. Given that P450 eicosanoids have multiple cardiovascular effects, pharmacological modulation of their formation and/or degradation may yield therapeutic benefits.

This article has been cited by other articles:

				A. E. EnayetAllah, A. Luria, B. Luo, H.-J. Tsai, P. Sura, B. D. Hammock, and D. F. Grant Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase J. Biol. Chem., December 26, 2008; 283(52): 36592 - 36598. [Abstract] [Full Text] [PDF]

				M. Fer, L. Corcos, Y. Dreano, E. Plee-Gautier, J.-P. Salaun, F. Berthou, and Y. Amet Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism J. Lipid Res., November 1, 2008; 49(11): 2379 - 2389. [Abstract] [Full Text] [PDF]

				B. N. M. Zordoky, M. E. Aboutabl, and A. O. S. El-Kadi Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats Drug Metab. Dispos., November 1, 2008; 36(11): 2277 - 2286. [Abstract] [Full Text] [PDF]

				J. Antoun, S. Goulitquer, Y. Amet, Y. Dreano, J.-P. Salaun, L. Corcos, and E. Plee-Gautier CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis J. Lipid Res., October 1, 2008; 49(10): 2135 - 2141. [Abstract] [Full Text] [PDF]